{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T19:48:05Z","timestamp":1777924085203,"version":"3.51.4"},"reference-count":71,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.hpb.2020.07.011","type":"journal-article","created":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T02:06:21Z","timestamp":1596765981000},"page":"1513-1520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Cholecystectomy as a risk factor for non-alcoholic fatty liver disease development"],"prefix":"10.1016","volume":"22","author":[{"given":"Itzayana","family":"Rodr\u00edguez-Antonio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo N.","family":"L\u00f3pez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor Y.","family":"Garrido-Camacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misael","family":"Uribe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norberto C.","family":"Ch\u00e1vez-Tapia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7616-2661","authenticated-orcid":false,"given":"Natalia","family":"Nu\u00f1o-L\u00e1mbarri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2020.07.011_bib1","doi-asserted-by":"crossref","first-page":"15539","DOI":"10.3748\/wjg.v20.i42.15539","article-title":"Histopathology of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"20","author":"Takahashi","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hpb.2020.07.011_bib2","first-page":"98","article-title":"Archivos de Medicina","volume":"16","author":"D\u00edaz-Rosales","year":"2016","journal-title":"Arch Med"},{"key":"10.1016\/j.hpb.2020.07.011_bib3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MOG.0b013e32801421a9","article-title":"Fatty liver and the metabolic syndrome","volume":"23","author":"Neuschwander-Tetri","year":"2007","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.hpb.2020.07.011_bib4","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.hpb.2020.07.011_bib5","article-title":"The grade of nonalcoholic fatty liver disease is an independent risk factor for gallstone disease","volume":"98","author":"Kim","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.hpb.2020.07.011_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2011.03.020","article-title":"Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008","volume":"9","author":"Younossi","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.hpb.2020.07.011_bib7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/apt.13012","article-title":"Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey","volume":"41","author":"Ruhl","year":"2015","journal-title":"Aliment Pharmacol Therapeut"},{"key":"10.1016\/j.hpb.2020.07.011_bib8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.hpb.2020.07.011_bib9","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1053\/gast.2001.23256","article-title":"Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities","volume":"120","author":"Sanyal","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hpb.2020.07.011_bib10","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1053\/gast.2002.32403","article-title":"Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease","volume":"122","author":"Facchini","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hpb.2020.07.011_bib11","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1053\/j.gastro.2015.08.011","article-title":"Heritability of hepatic fibrosis and steatosis based on a prospective twin study","volume":"149","author":"Loomba","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hpb.2020.07.011_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1172\/JCI200317797","article-title":"The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice","volume":"112","author":"Xu","year":"2003","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.hpb.2020.07.011_bib13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0140-6736(06)69044-2","article-title":"Cholesterol gallstone disease","volume":"368","author":"Portincasa","year":"2006","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.hpb.2020.07.011_bib14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/MOG.0000000000000511","article-title":"Genetics of gallstone disease revisited: updated inventory of human lithogenic genes","volume":"35","author":"Weber","year":"2019","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.hpb.2020.07.011_bib15","doi-asserted-by":"crossref","first-page":"6546","DOI":"10.3748\/wjg.v18.i45.6546","article-title":"Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease","volume":"18","author":"Li","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hpb.2020.07.011_bib16","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/ajg.2013.84","article-title":"Cholecystectomy and NAFLD: does gallbladder removal have metabolic consequences?","volume":"108","author":"Nervi","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.hpb.2020.07.011_bib17","doi-asserted-by":"crossref","first-page":"16024","DOI":"10.1038\/nrdp.2016.24","article-title":"Gallstones","volume":"2","author":"Lammert","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.hpb.2020.07.011_bib18","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1172\/JCI110209","article-title":"Role of gallbladder mucus hypersecretion in the evolution of cholesterol gallstones. Studies in the prairie dog","volume":"67","author":"Lee","year":"1981","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.hpb.2020.07.011_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1308\/003588411X563402","article-title":"Acalculous gallbladder disease: the outcomes of treatment by laparoscopic cholecystectomy","volume":"93","author":"Ahmed","year":"2011","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1016\/j.hpb.2020.07.011_bib20","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0039-6109(05)70456-4","article-title":"Changing indications for laparoscopic cholecystectomy","volume":"76","author":"Schwesinger","year":"2005","journal-title":"Surg Clin N Am"},{"key":"10.1016\/j.hpb.2020.07.011_bib21","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1007\/s10620-009-1035-6","article-title":"Surgeon volume metrics in laparoscopic cholecystectomy","volume":"55","author":"Csikesz","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.hpb.2020.07.011_bib22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a population-based cohort study","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hpb.2020.07.011_bib23","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1053\/j.gastro.2010.10.060","article-title":"Gallstone disease is associated with increased mortality in the United States","volume":"140","author":"Ruhl","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hpb.2020.07.011_bib24","doi-asserted-by":"crossref","first-page":"5169","DOI":"10.2174\/13816128113199990336","article-title":"Epidemiology and natural history of patients with NAFLD","volume":"19","author":"Bhala","year":"2013","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.hpb.2020.07.011_bib25","doi-asserted-by":"crossref","first-page":"172","DOI":"10.5009\/gnl.2012.6.2.172","article-title":"Epidemiology of gallbladder disease: cholelithiasis and cancer","volume":"6","author":"Stinton","year":"2012","journal-title":"Gut Liver"},{"key":"10.1016\/j.hpb.2020.07.011_bib26","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.hpb.2020.07.011_bib27","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1572-0241.2005.41214.x","article-title":"Strong association between gallstones and cardiovascular disease","volume":"100","author":"M\u00e9ndez-S\u00e1nchez","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.hpb.2020.07.011_bib28","doi-asserted-by":"crossref","unstructured":"Chavez-Tapia NC, Kinney-Novelo I Mac, Sifuentes-Renter\u00eda SE, Torres-Zavala M, Castro-Gastelum G, S\u00e1nchez-Lara K, et\u00a0al. Association between cholecystectomy for gallstone disease and risk factors for cardiovascular disease. Ann Hepatol 11: 85\u201389.","DOI":"10.1016\/S1665-2681(19)31490-5"},{"key":"10.1016\/j.hpb.2020.07.011_bib29","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/ajg.2013.70","article-title":"Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population","volume":"108","author":"Ruhl","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.hpb.2020.07.011_bib30","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.3748\/wjg.v21.i20.6287","article-title":"Cholecystectomy is independently associated with nonalcoholic fatty liver disease in an Asian population","volume":"21","author":"Kwak","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hpb.2020.07.011_bib31","article-title":"Association of cholecystectomy with metabolic syndrome in a Chinese population","volume":"9","author":"Shen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.hpb.2020.07.011_bib32","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.3748\/wjg.v11.i11.1653","article-title":"Metabolic syndrome as a risk factor for gallstone disease","volume":"11","author":"M\u00e9ndez-S\u00e1nchez","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hpb.2020.07.011_bib33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/00365521.2011.643481","article-title":"Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors","volume":"47","author":"Koller","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.hpb.2020.07.011_bib34","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1440-1746.2005.03924.x","article-title":"Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors","volume":"20","author":"Loria","year":"2005","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.hpb.2020.07.011_bib35","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12876-014-0213-y","article-title":"Non-alcoholic fatty liver disease associated with gallstones in females rather than males: a longitudinal cohort study in Chinese urban population","volume":"14","author":"Liu","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.hpb.2020.07.011_bib36","doi-asserted-by":"crossref","first-page":"313","DOI":"10.5009\/gnl.2014.8.3.313","article-title":"Gallstone disease does not predict liver histology in nonalcoholic fatty liver disease","volume":"8","author":"Yilmaz","year":"2014","journal-title":"Gut Liver"},{"key":"10.1016\/j.hpb.2020.07.011_bib37","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/MOG.0000000000000416","article-title":"Nonalcoholic fatty liver disease, cholesterol gallstones, and cholecystectomy: new insights on a complex relationship","volume":"34","author":"Arrese","year":"2018","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.hpb.2020.07.011_bib38","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1007\/s00268-015-3396-7","article-title":"Cholecystectomy causes ultrasound evidence of increased hepatic steatosis","volume":"40","author":"Yun","year":"2016","journal-title":"World J Surg"},{"key":"10.1016\/j.hpb.2020.07.011_bib39","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1007\/s00268-016-3484-3","article-title":"Association between cholecystectomy and nonalcoholic fatty liver disease: a meta-analysis","volume":"40","author":"Jaruvongvanich","year":"2016","journal-title":"World J Surg"},{"key":"10.1016\/j.hpb.2020.07.011_bib40","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/j.2040-4603.2016.tb00717.x","article-title":"Functions of the gallbladder","volume":"6","author":"Housset","year":"2016","journal-title":"Compr Physiol"},{"key":"10.1016\/j.hpb.2020.07.011_bib41","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-017-0525-3","article-title":"Effect of cholecystectomy on hepatic fat accumulation and insulin resistance in non-obese hispanic patients: a pilot study","volume":"16","author":"Cort\u00e9s","year":"2017","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.hpb.2020.07.011_bib42","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nm1785","article-title":"Hepatic insulin resistance directly promotes formation of cholesterol gallstones","volume":"14","author":"Biddinger","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.hpb.2020.07.011_bib43","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3390\/nu9040387","article-title":"Nonalcoholic fatty liver disease and insulin resistance: new insights and potential new treatments","volume":"9","author":"Kitade","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.hpb.2020.07.011_bib44","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.tem.2013.04.001","article-title":"The regulation of ApoB metabolism by insulin","volume":"24","author":"Haas","year":"2013","journal-title":"Trends Endocrinol Metabol"},{"key":"10.1016\/j.hpb.2020.07.011_bib45","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00535-013-0758-5","article-title":"Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease","volume":"48","author":"Kawano","year":"2013","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.hpb.2020.07.011_bib46","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1073\/pnas.0914798107","article-title":"Bifurcation of insulin signaling pathway in rat liver: MTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis","volume":"107","author":"Li","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.hpb.2020.07.011_bib47","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","article-title":"Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease","volume":"146","author":"Lambert","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hpb.2020.07.011_bib48","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.2174\/092986707781368540","article-title":"Hepatobiliary diseases and insulin resistance","volume":"14","author":"Mendez-Sanchez","year":"2007","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.hpb.2020.07.011_bib49","doi-asserted-by":"crossref","first-page":"e12983","DOI":"10.1111\/obr.12983","article-title":"Pathophysiological connections between gallstone disease, insulin resistance, and obesity","volume":"21","author":"Cort\u00e9s","year":"2020","journal-title":"Obes Rev"},{"key":"10.1016\/j.hpb.2020.07.011_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118478","article-title":"Metabolic effects of cholecystectomy: gallbladder ablation increases basal metabolic rate through G-protein coupled bile acid receptor Gpbar1-dependent mechanisms in mice","volume":"10","author":"Cort\u00e9s","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.hpb.2020.07.011_bib51","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metab"},{"key":"10.1016\/j.hpb.2020.07.011_bib52","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physrev.00010.2008","article-title":"Role of bile acids and bile acid receptors in metabolic regulation","volume":"89","author":"Lefebvre","year":"2009","journal-title":"Physiol Rev"},{"key":"10.1016\/j.hpb.2020.07.011_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2015.00193","article-title":"Fibroblast growth factor signaling in metabolic regulation","volume":"6","author":"Nies","year":"2016","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.hpb.2020.07.011_bib54","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1515\/jpem-2012-0253","article-title":"A\u00a0decrease in fasting FGF19 levels is associated with the development of non-alcoholic fatty liver disease in obese adolescents","volume":"25","author":"Wojcik","year":"2012","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.hpb.2020.07.011_bib55","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1210\/en.2003-1671","article-title":"Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes","volume":"145","author":"Fu","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.hpb.2020.07.011_bib56","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000371670","article-title":"Bile acids as hormones: the FXR-FGF15\/19 pathway","volume":"33","author":"Kliewer","year":"2015","journal-title":"Dig Dis"},{"key":"10.1016\/j.hpb.2020.07.011_bib57","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/hep.1840210109","article-title":"Long-term effects of cholecystectomy on bile acid metabolism","volume":"21","author":"Kullak-Ublick","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.hpb.2020.07.011_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067160","article-title":"Association between serum atypical fibroblast growth factors 21 and 19 and pediatric nonalcoholic fatty liver disease","volume":"8","author":"Alisi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.hpb.2020.07.011_bib59","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000282091","article-title":"Bile acids as regulators of hepatic lipid and glucose metabolism","volume":"28","author":"Trauner","year":"2010","journal-title":"Dig Dis"},{"key":"10.1016\/j.hpb.2020.07.011_bib60","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/hep.24148","article-title":"Nuclear receptors in liver disease","volume":"53","author":"Wagner","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.hpb.2020.07.011_bib61","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1056\/NEJM197312062892302","article-title":"Bile acid pools, kinetics and biliary lipid composition before and after cholecystectomy","volume":"289","author":"Almond","year":"1973","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hpb.2020.07.011_bib62","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/BF01076595","article-title":"Bile acid secretion and biliary bile acid composition altered by cholecystectomy","volume":"18","author":"Malagelada","year":"1973","journal-title":"Am J Dig Dis"},{"key":"10.1016\/j.hpb.2020.07.011_bib63","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/hep.28709","article-title":"Bile acids and nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives","volume":"65","author":"Arab","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.hpb.2020.07.011_bib64","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1074\/jbc.M605023200","article-title":"The liver X receptor (LXR) and hepatic lipogenesis","volume":"282","author":"Cha","year":"2007","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.hpb.2020.07.011_bib65","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.pharmthera.2017.05.011","article-title":"Targeting nuclear receptors for the treatment of fatty liver disease","volume":"179","author":"Tanaka","year":"2017","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.hpb.2020.07.011_bib66","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/hep.22175","article-title":"Activation of liver X receptor sensitizes mice to gallbladder cholesterol crystallization","volume":"47","author":"Uppal","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.hpb.2020.07.011_bib67","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/nm1138","article-title":"Prevention of cholesterol gallstone disease by FXR agonists in a mouse model","volume":"10","author":"Moschetta","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.hpb.2020.07.011_bib68","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S1091-255X(02)00418-3","article-title":"Incidence and management of biliary pancreatitis in cholecystectomized patients. Results of a 7-year study","volume":"7","author":"Gloor","year":"2003","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.hpb.2020.07.011_bib69","first-page":"S15","article-title":"The role of bile acids in glucose metabolism and their relation with diabetes the role of bile acids in glucose metabolism and their relation with diabetes","volume":"16","author":"Alberto Gonz\u00e1lez-Regueiro","year":"2017"},{"key":"10.1016\/j.hpb.2020.07.011_bib70","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1210\/me.2010-0460","article-title":"The G protein-coupled bile acid receptor, TGR5, stimulates gallbladder filling","volume":"25","author":"Li","year":"2011","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.hpb.2020.07.011_bib71","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.clinre.2012.03.008","article-title":"Perspective: TGR5 (Gpbar-1) in liver physiology and disease","volume":"36","author":"Keitel","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X20311059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X20311059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:28:37Z","timestamp":1761265717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X20311059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":71,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1365182X20311059"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2020.07.011","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cholecystectomy as a risk factor for non-alcoholic fatty liver disease development","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2020.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}